Publications To Date


    Filter Publications

    PAGE 6 OF 78 | DISPLAYING 76 - 90 OF 1166 RESULTS

    Schreiber LM et al., The lytic activity of VSV-GP treatment dominates the therapeutic effects in a syngeneic model of lung cancer., , Br J Cancer, Sep 18, 2019

    Ronsley R et al., The TLR9 agonist (GNKG168) induces a unique immune activation pattern in vivo in children with minimal residual disease positive acute leukemia: Results of the TACL T2009-008 phase I study., , Pediatr Hematol Oncol, Sep 18, 2019

    Adamo B et al., Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial., , Breast Cancer Res, Sep 18, 2019

    Octeau D et al., Outcome-Related Differences in Gene Expression Profiles of High Grade Serous Ovarian Cancers Following Neoadjuvant Chemotherapy., , Mol Cancer Res, Sep 17, 2019

    Staiger AM et al., A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHL., , Leukemia, Sep 17, 2019

    Park IH et al., Anti-tumor activity of BET inhibitors in androgen-receptor-expressing triple-negative breast cancer., , Sci Rep, Sep 16, 2019

    Penyige A et al., Circulating miRNA Profiling in Plasma Samples of Ovarian Cancer Patients., , Int J Mol Sci, Sep 13, 2019

    Li K et al., Preoperative Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio are Associated with the Prognosis of Group 3 and Group 4 Medulloblastoma., , Sci Rep, Sep 13, 2019

    Penyige A et al., Circulating miRNA Profiling in Plasma Samples of Ovarian Cancer Patients., , Int J Mol Sci, Sep 13, 2019

    Haratani K et al., Clinical and immune profiling for cancer of unknown primary site., , J Immunother Cancer, Sep 13, 2019

    Roberto D et al., Functional validation of metabolic genes that distinguish Gleason 3 from Gleason 4 prostate cancer foci., , Prostate, Sep 10, 2019

    McQuerry et al., Pathway activity profiling of growth factor receptor network and stemness pathways differentiates metaplastic breast cancer histological subtypes, , BMC Cancer., Sep 10, 2019

    Dejene SB et al., Defining fallopian tube‐derived miRNA cancer signatures., , Cancer Med, Sep 10, 2019

    Zhang F et al., Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers., , Nat Commun, Sep 03, 2019

    Yang Y et al., Amplification of 9p24.1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphoma., , Blood Cancer J., Aug 30, 2019